|1|The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder. (24268564)
Rothschild A.J.... Fava M.
|2|Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. (24882425)
Pearlman D.M.... Najjar S.
|3|Comment on the prescription of exercise for major depressive disorder: reply to Drs. Rethorst and Trivedi. (23852100)
Stanton R.... Rosenbaum S.
|4|Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences. (24107761)
Zimmerman M.... Dalrymple K.
|5|Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder. (23529111)
Liu Z.... Xiao Z.
|6|Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder. (23813968)
Yoshimura R.... Nakamura J.
|7|Changes in Heart Rate Variability before and after ECT in the Treatment of Resistant Major Depressive Disorder. (24029110)
Bozkurt A.... Ozmenler K.N.
|8|Differential impact of isolated psychotic symptoms on treatment outcome of major depressive disorder in the STAR*D cohort of Whites, Blacks and Latinos. (23489398)
Cassano P.... Mischoulon D.
|9|Psychotic versus non-psychotic major depressive disorder: a comparative naturalistic study. (23810143)
Buoli M.... Altamura A.C.
|10|Functional connectivity between the amygdala and prefrontal cortex in medication-naive individuals with major depressive disorder. (24148846)
Kong L.... Wang F.
|11|Is there a cerebellar compensatory effort in first-episode, treatment-naive major depressive disorder at rest? (23800464)
Guo W.... Xiao C.
|12|The serotonin transporter gene locus in late-life major depressive disorder. (23290204)
Seripa D.... Pilotto A.
|13|Obsessive beliefs in patients with major depressive disorder. (24164496)
Bahceci B.... Hocaoglu C.
|14|Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder. (23567397)
Katila H.... Datto C.
|15|Whole-brain functional connectivity during emotional word classification in medication-free Major Depressive Disorder: Abnormal salience circuitry and relations to positive emotionality. (24179829)
van Tol M.J.... Johnstone T.
|16|Effectiveness and cost effectiveness of guided online treatment for patients with major depressive disorder on a waiting list for psychotherapy: study protocol of a randomized controlled trial. (24289099)
Kenter R.M.... Cuijpers P.
|17|Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate. (24067192)
Clayton A.H.... McIntyre R.S.
|18|Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder. (23374637)
Gray N.A.... Parsey R.V.
|19|Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetine. (23425292)
Cui Z.... Novick D.
|20|The effect of escitalopram on metabolic parameters in patients with major depressive disorder, generalised anxiety disorder, and panic disorder: a prospective 6-month follow-up study. (23642988)
Peh A.L.... Koon O.G.
|21|Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence. (23325372)
Han D.H.... Renshaw P.F.
|22|Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series. (24247862)
De Berardis D.... Di Giannantonio M.
|23|Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder. (23229074)
|24|Phenotypic differences between pregnancy-onset and postpartum-onset major depressive disorder. (23290332)
Altemus M.... Bleiberg K.L.
|25|Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder. (22609366)
Murphy M.L.... Frodl T.
|26|The role of single nucleotide polymorphism of D2 dopamine receptor gene on major depressive disorder and response to antidepressant treatment. (22796099)
Wang Y.... Ma X.
|27|Increased symptoms of attention deficit hyperactivity disorder and major depressive disorder symptoms in Nail-patella syndrome: potential association with LMX1B loss-of-function. (21184584)
LA^pez-Arvizu C.... Tierney E.
|28|Intolerance of uncertainty, worry, and rumination in major depressive disorder and generalized anxiety disorder. (20439149)
Yook K.... Lee K.S.
|29|Association analysis of SIGMAR1 with major depressive disorder and SSRI response. (20178807)
Kishi T.... Iwata N.
|30|Correlation of major depressive disorder symptoms with FKBP5 but not FKBP4 expression in human immunodeficiency virus-infected individuals. (20726698)
Tatro E.T.... Everall I.P.
|31|Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes. (20822372)
Kocabas N.A.... Mendlewicz J.
|32|The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder. (20584552)
Gudayol-FerrAc E.... GuA rdia-Olmos J.
|33|Efficacy, safety, and tolerability of Desvenlafaxine 50 mg/d for the treatment of major depressive disorder:a systematic review of clinical trials. (20944767)
Liebowitz M.R.... Tourian K.A.
|34|Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder. (19900711)
Li Y.... Yang H.
|35|Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder. (21152026)
Glessner J.T.... Hakonarson H.
|36|Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence. (19086875)
Kamath J.... Handratta V.
|37|Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy. (17956625)
Carta M.G.... Farci P.
|38|Comparing postpartum depression and major depressive disorder: issues in assessment. (17654110)
Jolley S.N.... Betrus P.
|39|Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. (17346943)
Brundin L.... TrAoskman-Bendz L.
|40|Major depressive disorder, sleep EEG and agomelatine: an open-label study. (17477886)
Quera Salva M.A.... Guilleminault C.
|41|Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response. (17417063)
Jabbi M.... den Boer J.A.
|42|Number of risk genotypes is a risk factor for major depressive disorder: a case control study. (16822313)
Garriock H.A.... Moreno F.A.
|43|Neurocognitive differential diagnosis of dementing diseases: Alzheimer's Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder. (17000529)
Braaten A.J.... Burns W.J.
|44|Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. (16259548)
Papakostas G.I.... Nierenberg A.A.
|45|Neurokinin-1 receptors are decreased in major depressive disorder. (12151774)
Stockmeier C.A.... Rajkowska G.
|46|Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder. (12502014)
Yoshida K.... Otani K.
|47|Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. (11426508)
Du L.... Hrdina P.D.
|48|Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder. (11041531)
Bayer T.A.... Falkai P.
|49|Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder. (10440460)
Fava M.... Magni G.
|50|Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. (9219044)
Bakish D.... Thibaudeau C.A.